David R. Van Wagoner

23.0k total citations · 4 hit papers
113 papers, 8.7k citations indexed

About

David R. Van Wagoner is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Physiology. According to data from OpenAlex, David R. Van Wagoner has authored 113 papers receiving a total of 8.7k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Cardiology and Cardiovascular Medicine, 38 papers in Molecular Biology and 10 papers in Physiology. Recurrent topics in David R. Van Wagoner's work include Atrial Fibrillation Management and Outcomes (41 papers), Cardiac electrophysiology and arrhythmias (41 papers) and Cardiac Arrhythmias and Treatments (20 papers). David R. Van Wagoner is often cited by papers focused on Atrial Fibrillation Management and Outcomes (41 papers), Cardiac electrophysiology and arrhythmias (41 papers) and Cardiac Arrhythmias and Treatments (20 papers). David R. Van Wagoner collaborates with scholars based in United States, United Kingdom and Canada. David R. Van Wagoner's co-authors include Mina K. Chung, Patrick M. McCarthy, Jeanne M. Nerbonne, Amber Pond, Stanley Nattel, Masafumi Harada, Cynthia A. Carnes, Patrick Tchou, Todor N. Mazgalev and John Anthony Bauer and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Gastroenterology.

In The Last Decade

David R. Van Wagoner

110 papers receiving 8.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inflammation as a Risk Factor for Atrial Fibrillation

2003 1.1k citations David R. Van Wagoner, Mina K. Chung et al. Circulation profile →
Pathophysiology and Prevention of Atrial Fibrillation

2001 541 citations David R. Van Wagoner et al. Circulation profile →
Impaired Myofibrillar Energetics and Oxidative Injury During Human Atrial Fibrillation

2001 531 citations David R. Van Wagoner et al. Circulation profile →
Role of Inflammation in Atrial Fibrillation Pathophysiology and Management

2015 358 citations Masafumi Harada, David R. Van Wagoner et al. profile →

Peers

Countries citing papers authored by David R. Van Wagoner

Since Specialization

Citations

This map shows the geographic impact of David R. Van Wagoner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David R. Van Wagoner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David R. Van Wagoner more than expected).

Fields of papers citing papers by David R. Van Wagoner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David R. Van Wagoner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David R. Van Wagoner. The network helps show where David R. Van Wagoner may publish in the future.

Co-authorship network of co-authors of David R. Van Wagoner

This figure shows the co-authorship network connecting the top 25 collaborators of David R. Van Wagoner. A scholar is included among the top collaborators of David R. Van Wagoner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David R. Van Wagoner. David R. Van Wagoner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Polysomnographic sleep architectural disruption associated with atrial fibrillation development 2025 ·SLEEP ·(unknown), Nicolas R. Thompson, Alex Milinovich, Matheus Araújo, (unknown), Nancy Foldvary‐Schaefer, Michael Faulx, David R. Van Wagoner, Mina K. Chung, Reena Mehra	0
2	Novel Sleep Phenotypic Profiles Associated With Incident Atrial Fibrillation in a Large Clinical Cohort 2024 ·JACC. Clinical electrophysiology ·(unknown), Brittany Lapin, (unknown), Yadi Li, Alex Milinovich, Anna M. May, (unknown), Michael Faulx, David R. Van Wagoner, Mina K. Chung, Nancy Foldvary‐Schaefer, Reena Mehra	4
3	Transcriptomic Insights into the Atrial Fibrillation Susceptibility Locus near the MYOZ1 and SYNPO2L Genes 2024 ·International Journal of Molecular Sciences ·(unknown), (unknown), (unknown), (unknown), David R. Van Wagoner, Mina K. Chung, John Barnard, Jonathan D. Smith	3
4	Common SYNE2 Genetic Variant Associated With Atrial Fibrillation Lowers Expression of Nesprin-2α1 With Downstream Effects on Nuclear and Electrophysiological Traits 2024 ·Circulation Genomic and Precision Medicine ·(unknown), Jeffrey Hsu, Gautam Mahajan, (unknown), Kenneth R. Laurita, Sathyamangla V Naga Prasad, John Barnard, David R. Van Wagoner, Chandrasekhar R. Kothapalli, Mina K. Chung, Jonathan D. Smith	1
5	Sleep‐Disordered Breathing, Hypoxia, and Pulmonary Physiologic Influences in Atrial Fibrillation 2023 ·Journal of the American Heart Association ·(unknown), (unknown), Alex Milinovich, Matheus Araújo, (unknown), Nancy Foldvary‐Schaefer, Philippe Haouzi, Michael Faulx, David R. Van Wagoner, Mina K. Chung, Reena Mehra	2
6	Decreased FAM13B Expression Increases Atrial Fibrillation Susceptibility by Regulating Sodium Current and Calcium Handling 2023 ·JACC Basic to Translational Science ·(unknown), Daniela Ponce‐Balbuena, Nana Liu, (unknown), Jeffrey Hsu, Fang Liu, (unknown), Gregory Brubaker, Sarah M. Schumacher, Christine S. Moravec, John Barnard, David R. Van Wagoner, Mina K. Chung, Jonathan D. Smith	3
7	Novel functional atrial fibrillation risk genes and pathways identified from coexpression analyses in human left atria 2023 ·Heart Rhythm ·(unknown), (unknown), Han Sun, Jeffrey Hsu, Julie H. Rennison, (unknown), (unknown), A. Marc Gillinov, Christine S. Moravec, Jonathan D. Smith, David R. Van Wagoner, John Barnard, Mina K. Chung	7
8	Atrial fibrillation rhythm is associated with marked changes in metabolic and myofibrillar protein expression in left atrial appendage 2021 ·Pflügers Archiv - European Journal of Physiology ·Julie H. Rennison, Ling Li, (unknown), (unknown), Laurie Castel, (unknown), (unknown), (unknown), A. Marc Gillinov, Reena Mehra, Belinda Willard, Jonathan D. Smith, Mina K. Chung, John Barnard, David R. Van Wagoner	16
9	Activated intestinal muscle cells promote preadipocyte migration: a novel mechanism for creeping fat formation in Crohn’s disease 2021 ·Gut ·Ren Mao, Geneviève Doyon, Ilyssa O. Gordon, Jiannan Li, Sinan Lin, Jie Wang, (unknown), Michael Elias, Satya Kurada, Brian D. Southern, Mitchell A. Olman, Minhu Chen, Shuai Zhao, (unknown), Jyotsna Chandra, Pranab K. Mukherjee, Gail West, David R. Van Wagoner, Claudio Fiocchi, Florian Rieder	46
10	Cardiac Pressure Overload Decreases ETV1 Expression in the Left Atrium, Contributing to Atrial Electrical and Structural Remodeling 2020 ·Circulation ·Naoko Yamaguchi, Junhua Xiao, (unknown), (unknown), Xianming Lin, (unknown), Alireza Khodadadi‐Jamayran, Akshay Shekhar, (unknown), (unknown), David R. Van Wagoner, Mina K. Chung, David Park	29
11	The burden of proof: The current state of atrial fibrillation prevention and treatment trials 2017 ·Heart Rhythm ·Rosita Zakeri, David R. Van Wagoner, Hugh Calkins, Tom Wong, Heather Ross, E. Kevin Heist, Timothy E. Meyer, Peter R. Kowey, Robert J. Mentz, John G.F. Cleland, Bertram Pitt, Faı̈ez Zannad, Cecilia Linde	29
12	Cardiac Autonomic Nerve Stimulation in the Treatment of Heart Failure 2013 ·The Annals of Thoracic Surgery ·Mariko Kobayashi, Alex Massiello, Jamshid H. Karimov, David R. Van Wagoner, Kiyotaka Fukamachi	26
13	Transient Receptor Potential Canonical-3 Channel–Dependent Fibroblast Regulation in Atrial Fibrillation 2012 ·Circulation ·Masafumi Harada, Xiaobin Luo, Xiao Yan Qi, Artavazd Tadevosyan, Ange Maguy, Balázs Ördög, Jonathan Ledoux, Takeshi Kato, Patrice Naud, Niels Voigt, Yanfen Shi, Kaichiro Kamiya, Toyoaki Murohara, Itsuo Kodama, Jean‐Claude Tardif, Ulrich Schotten, David R. Van Wagoner, Dobromir Dobrev, Stanley Nattel	210
14	Abstract 8221: Cis Regulation of Genes in Human Atria Near SNPs Associated with Atrial Fibrillation and PR Interval 2011 ·Circulation ·Mina K. Chung, John Barnard, Peter Hanna, Jeffrey Hsu, (unknown), Robert Wirka, (unknown), David Serre, Jonathan D. Smith, David R. Van Wagoner	1
15	Dietary ω3 fatty acids modulate the substrate for post-operative atrial fibrillation in a canine cardiac surgery model 2010 ·Cardiovascular Research ·Fadia Mayyas, (unknown), Rashmi Ram, Julie H. Rennison, (unknown), Laurie Castel, (unknown), Marie-Luise Brennan, Douglas M. Bibus, Bill Lands, John Barnard, Mina K. Chung, David R. Van Wagoner	41
16	Elucidation of a TRPC6-TRPC5 Channel Cascade That Restricts Endothelial Cell Movement 2008 ·Molecular Biology of the Cell ·Pinaki Chaudhuri, Scott M. Colles, Manjunatha B. Bhat, David R. Van Wagoner, Lutz Birnbaumer, Linda M. Graham	77
17	An Experimental Rabbit Model for Off-Pump Left Ventricular Reconstruction Following Left Ventricular Aneurysm 2006 ·The Heart Surgery Forum ·Yoshio Ootaki, Hirotsugu Yamada, Masao Daimon, Keiji Kamohara, Zoran Popović, David R. Van Wagoner, Yuanna Cheng, Kiyotaka Fukamachi	3
18	Localization of Kv1.5 channels in rat and canine myocyte sarcolemma 2006 ·FEBS Letters ·Jodene Eldstrom, David R. Van Wagoner, Edwin D.W. Moore, David Fedida	37
19	Electrophysiological Remodeling in Human Atrial Fibrillation 2003 ·Pacing and Clinical Electrophysiology ·David R. Van Wagoner	79
20	Molecular Basis of Electrical Remodeling in Atrial Fibrillation 2000 ·Journal of Molecular and Cellular Cardiology ·David R. Van Wagoner, Jeanne M. Nerbonne	117

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact